Operating profit before deduction of amortization: Avalo Therapeutics (AVTX)
Avalo Therapeutics, Inc (AVTX) relies on external financing due to a lack of profitable products and negative cash flow. The EBITDA_Co trend reflects the asset's current resilience, with the current value standing at 0.00. The company's prospects are based on the creation of targeted antibodies to the LIGHT cytokine and the development of innovative cell-signaling blockade methods for the therapy of severe autoimmune skin and lung lesions.
avalotx.com (AVTX) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio Avalo Therapeutics, Inc|AVTX - Long-Term Debt to Capital|Current Liabilities to Capital Avalo Therapeutics Inc.|AVTX - Company Aggregate Debts|Debts to Book Capitalization Avalo Therapeutics, Inc|AVTX - Company Long-Term Liabilities|Company Short-Term Debt Avalo Therapeutics|Quick Ratio avalotx.com
- earnings and multiples data:
AVTX - Company Net Income|Expected Profit Avalo Therapeutics, Inc|AVTX - Price to Earnings Ratio|Projected Price to Earnings Ratio Avalo Therapeutics Inc.|AVTX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Avalo Therapeutics, Inc|AVTX - Operating profit before deduction of amortization|Earnings per share for the last four quarters Avalo Therapeutics|AVTX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months avalotx.com|AVTX - Earnings growth in current year|Expected net earnings per share growth next year Avalo Therapeutics, Inc
- sales and revenue indicators:
Summary company analytics:AVTX (Avalo Therapeutics)
Professional asset selection is based on comparing current operating profit with historical data to assess the rate of capital reproduction. By analyzing the underlying operating result before depreciation, an investor measures the actual cash flow from core operations, which serves as a critical viability indicator between equity offering stages for the speculative business of Avalo Therapeutics (AVTX) facing liquidity depletion risks.
Competitor analysis for Avalo Therapeutics, Inc
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Aclaris - Income before deduction of interest, taxes and amortization|KYTX (Kyverna Therapeutics, Inc) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio)|VTYX - Profit before interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies, Inc)|Eledon Pharmaceuticals (ELDN) - Profit before interest, taxes and amortization|Agenus, Inc - Operating profit EBITDA|Profit before interest, taxes and amortization climbbio.com|ZURA (Zura Bio Limited) - Operating profit before deduction of amortization|aTyr (ATYR) - Operating profit EBITDA|Operating profit before deduction of amortization ADAG|IMA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Shattuck Therapeutics (STTK)|Operating profit before deduction of amortization Equillium EQ|Connect Biopharma Holdings Limited - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMUX|ATRA - Profit before payment of interest, taxes and amortization|inflarx.de (IFRX) - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization X4 Pharmaceuticals XFOR|ACET - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization celularity.com|INMB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc (KZR)|Operating profit EBITDA SABS (SAB Biotherapeutics)|Operating profit EBITDA akaritx.com AKTX|Enlivex Therapeutics Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
